Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Maarten J Postma, Paul Beardsworth & Jan C Wilschut. (2008) Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes. Journal of Medical Economics 11:4, pages 743-768.
Read now
Read now
Asko Järvinen, Jaana Joutseno & Marlene Gyldmark. (2007) Cost effectiveness of oseltamivir for the treatment of influenza in adults, adolescents and children in Finland. Journal of Medical Economics 10:3, pages 199-214.
Read now
Read now
Beth L. Nordstrom, Iyue Sung, Pia Suter & Priscilla Szneke. (2005) Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir
. Current Medical Research and Opinion 21:5, pages 761-768.
Read now
Read now
Articles from other publishers (6)
Estela Capelas Barbosa, Talitha Irene Verhoef, Steve Morris, Francesca Solmi, Medina Johnson, Alex Sohal, Farah El-Shogri, Susanna Dowrick, Clare Ronalds, Chris Griffiths, Sandra Eldridge, Natalia V Lewis, Angela Devine, Anne Spencer & Gene Feder. (2018) Cost-effectiveness of a domestic violence and abuse training and support programme in primary care in the real world: updated modelling based on an MRC phase IV observational pragmatic implementation study. BMJ Open 8:8, pages e021256.
Crossref
Crossref
Laure-Anne Van Bellinghen, Genevieve Meier & Ilse Van Vlaenderen. (2014) The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model. PLoS ONE 9:6, pages e98437.
Crossref
Crossref
Sandra E. Talbird, Anita J. Brogan & Aleksander P. Winiarski. (2009) Oseltamivir for Influenza Postexposure Prophylaxis. American Journal of Preventive Medicine 37:5, pages 381-388.
Crossref
Crossref
Sandra E. Talbird, Anita J. Brogan, Aleksander P. Winiarski & Beate Sander. (2009) Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. American Journal of Health-System Pharmacy 66:5, pages 469-480.
Crossref
Crossref
Beate Sander, Azhar Nizam, Louis P. GarrisonJr.Jr., Maarten J. Postma, M. Elizabeth Halloran & Ira M. LonginiJr.Jr.. (2009) Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model. Value in Health 12:2, pages 226-233.
Crossref
Crossref
Maarten J Postma, Annoesjka Novak, Huib W K F H Scheijbeler, Marlene Gyldmark, Marianne L L van Genugten & Jan C Wilschut. (2007) Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza. PharmacoEconomics 25:6, pages 497-509.
Crossref
Crossref